1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Salivary Gland Neoplasm Duct: new trials by email Literature Review of Salivary Gland Neoplasm Duct trials Research Report on Salivary Gland Neoplasm Duct
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma Rezvilutamide, Leuprolide Acetate - Salivary Gland Neoplasm Duct | Phase 2 | Recruiting | Peking University First Hospital | 37 | 2024-10-10 | 2025-09-23 |
Leuprolide (1)
Peking University First Hospital (1)
China (1)